The use of technologies to monitor diabetes is expanding rapidly. The flash glucose monitoring (FSL) is allowed for clinical use in selected group of individuals with type 1 Diabetes in the UK. 

In GB, there are 1428 drivers with type 1 Diabetes who currently hold a Group 2 (lorry and bus) Driving licence. The regulation to allow insulin treated individuals with diabetes to drive, was allowed, several years ago when UK was an EU member.

TSJ Crabtree^1,2,3, K Dhatariya⁴, D Sennik⁵, A Rohilla⁵, S Sivappriyan⁶, D Barnes⁶, S Soo⁶, I Gallen⁷, REJ Ryder¹ on behalf of ABCD canagliflozin audit contributors⁹

1. Sandwell and West Birmingham Hospitals NHS Trust

2. University Hospitals of Derby and Burton NHS Trust

3. University of Nottingham

4. Norfolk and Norwich NHS Trust

5. Princess Alexandra Hospital NHS Trust; West Essex CCG

6. Maidstone and Tunbridge Wells NHS Trust

TSJ Crabtree^1,2,3, J Elliott⁴, A Bickerton⁵, A Evans⁶, S Phillips⁶, K Dhatariya⁷, I Gallen⁸, REJ Ryder¹; on behalf of ABCD empagliflozin audit contributors⁹

1 Sandwell and West Birmingham Hospitals NHS Trust

2 University Hospitals of Derby and Burton NHS Trust

3 University of Nottingham

4. Sheffield Teaching Hospitals NHS Trust

5 Yeovil District Hospitals NHS Foundation Trust

6 Gloucestershire Hospitals NHS Trust

The newly formed ABCD academic subcommittee are inviting applications from trainees in diabetes and endocrinology to join their board.

This is the third of our 2021 ABCD webinar series which run on the first Thursday of each month.

Junior doctors are invited to apply for a position with the Joint British Diabetes Societies for Inpatient Care (JBDS). This unremunerated post is designed to help refresh and update the existing guidelines that have been produced so far (all found at https://abcd.care/joint-british-diabetes-societies-jbds-inpatient-care-group), but also to help JBDS appreciate the needs of junior doctors.

We are inviting colleagues to submit entries to this year’s competition which will be:

‘Best intervention during the COVID-19 pandemic that has maintained inpatient safety for people with diabetes’